ÂÜÀòÂÒÂ×

Sherry Crowe is an accomplished professional in the oncology field with extensive experience in business development and marketing. Currently serving as Executive VP-Business Development at PrecisCa, Sherry has significantly contributed to enhancing cancer care through innovative consultancy roles, including Chief Executive Officer at OncoConnect LLC. Sherry has held pivotal positions on various Business Advisory Boards and has previously led business development at Ontada, a McKesson division, focusing on real-world evidence and provider education for biotechnology firms. Sherry's career includes notable achievements at Novartis Oncology, where Sherry excelled in commercial launch initiatives and market access for multiple oncology agents. With a foundation in oncology sales management at Roche Oncology and early career experience at Bristol Myers Squibb, Sherry is a proven leader in the oncology marketplace. Educational qualifications include degrees from the Lazaridis School of Business & Economics and Northwestern University's Kellogg School of Management.